{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:52Z","timestamp":1786119292156,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1097\/cji.0b013e31819d4e09","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T09:15:40Z","timestamp":1242897340000},"page":"370-375","source":"Crossref","is-referenced-by-count":6,"title":["Identification of an Immunogenic HLA-A*0201-binding T-cell Epitope of the Transcription Factor PAX2"],"prefix":"10.1097","volume":"32","author":[{"given":"Anne Marie","family":"Asemissen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen","family":"Haase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Stevanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Busse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckhard","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Georg","family":"Rammensee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Keilholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Scheibenbogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210219","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.immunol.24.021605.090733","article-title":"Human T cell responses against melanoma","volume":"24","author":"Boon","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"R2-6-20210219","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1470-2045(04)01610-9","article-title":"Part I: vaccines for solid tumours","volume":"5","author":"Mocellin","year":"2004","journal-title":"Lancet Oncol"},{"key":"R3-6-20210219","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1038\/sj.onc.1201114","article-title":"Differential regulation of the human Wilms tumour suppressor gene (WT1) promoter by two isoforms of PAX2","volume":"14","author":"McConnell","year":"1997","journal-title":"Oncogene"},{"key":"R4-6-20210219","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2141.2003.04622.x","article-title":"Possible regulation of Wilms' tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in human acute myeloid leukaemias","volume":"123","author":"Siehl","year":"2003","journal-title":"Br J Haematol"},{"key":"R5-6-20210219","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/modpathol.3800827","article-title":"Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Mullerian system origin?","volume":"20","author":"Tong","year":"2007","journal-title":"Mod Pathol"},{"key":"R6-6-20210219","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0022-5347(05)66304-5","article-title":"Expression of the developmental and oncogenic PAX2 gene in human prostate cancer","volume":"165","author":"Khoubehi","year":"2001","journal-title":"J Urol"},{"key":"R7-6-20210219","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/modpathol.3800320","article-title":"Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study","volume":"18","author":"Mazal","year":"2005","journal-title":"Mod Pathol"},{"key":"R8-6-20210219","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.1038\/sj.onc.1206766","article-title":"Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival","volume":"22","author":"Muratovska","year":"2003","journal-title":"Oncogene"},{"key":"R9-6-20210219","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/modpathol.3800588","article-title":"Immunohistochemical detection of WT1 protein in a variety of cancer cells","volume":"19","author":"Nakatsuka","year":"2006","journal-title":"Mod Pathol"},{"key":"R10-6-20210219","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1002\/j.1460-2075.1993.tb05890.x","article-title":"The oncogenic potential of Pax genes","volume":"12","author":"Maulbecker","year":"1993","journal-title":"Embo J"},{"key":"R11-6-20210219","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1002\/j.1460-2075.1995.tb00251.x","article-title":"Loss of p53 function through PAX-mediated transcriptional repression","volume":"14","author":"Stuart","year":"1995","journal-title":"Embo J"},{"key":"R12-6-20210219","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2353\/ajpath.2006.050776","article-title":"Expression of Pax2 in human renal tumor-derived endothelial cells sustains apoptosis resistance and angiogenesis","volume":"168","author":"Fonsato","year":"2006","journal-title":"Am J Pathol"},{"key":"R13-6-20210219","first-page":"4092","article-title":"Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides","volume":"55","author":"Gnarra","year":"1995","journal-title":"Cancer Res"},{"key":"R14-6-20210219","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/nature04225","article-title":"Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis","volume":"438","author":"Wu","year":"2005","journal-title":"Nature"},{"key":"R15-6-20210219","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2006.06.024","article-title":"PAX genes: roles in development, pathophysiology, and cancer","volume":"73","author":"Lang","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"R16-6-20210219","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrc1778","article-title":"A PANorama of PAX genes in cancer and development","volume":"6","author":"Robson","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"R17-6-20210219","first-page":"463","article-title":"Pax2 in development and renal disease","volume":"43","author":"Dressler","year":"1999","journal-title":"Int J Dev Biol"},{"key":"R18-6-20210219","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/dna.1993.12.381","article-title":"Murine Pax-2 protein is a sequence-specific trans-activator with expression in the genital system","volume":"12","author":"Fickenscher","year":"1993","journal-title":"DNA Cell Biol"},{"key":"R19-6-20210219","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0002-9440(10)62276-6","article-title":"Isolation of renal progenitor cells from adult human kidney","volume":"166","author":"Bussolati","year":"2005","journal-title":"Am J Pathol"},{"key":"R20-6-20210219","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1101\/gad.5.4.594","article-title":"The paired box encodes a second DNA-binding domain in the paired homeo domain protein","volume":"5","author":"Treisman","year":"1991","journal-title":"Genes Dev"},{"key":"R21-6-20210219","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.1158\/1078-0432.CCR-06-1337","article-title":"Identification of a highly immunogenic HLA-A*01-binding T cell epitope of WT1","volume":"12","author":"Asemissen","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R22-6-20210219","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002510050595","article-title":"SYFPEITHI: database for MHC ligands and peptide motifs","volume":"50","author":"Rammensee","year":"1999","journal-title":"Immunogenetics"},{"key":"R23-6-20210219","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00277-004-0941-0","article-title":"Expression of Wilms' tumor gene 1 at different stages of acute myeloid leukemia and analysis of its major splice variants","volume":"83","author":"Siehl","year":"2004","journal-title":"Ann Hematol"},{"key":"R24-6-20210219","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1182\/blood-2002-01-0163","article-title":"CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia","volume":"100","author":"Scheibenbogen","year":"2002","journal-title":"Blood"},{"key":"R25-6-20210219","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-1759(00)00257-X","article-title":"Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial","volume":"244","author":"Scheibenbogen","year":"2000","journal-title":"J Immunol Methods"},{"key":"R26-6-20210219","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ijc.10205","article-title":"Identification of known and novel immunogenic T-cell epitopes from tumor antigens recognized by peripheral blood T cells from patients responding to IL-2-based treatment","volume":"98","author":"Scheibenbogen","year":"2002","journal-title":"Int J Cancer"},{"key":"R27-6-20210219","doi-asserted-by":"crossref","first-page":"6350","DOI":"10.1158\/0008-5472.CAN-08-0050","article-title":"The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy","volume":"68","author":"Lehe","year":"2008","journal-title":"Cancer Res"},{"key":"R28-6-20210219","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/44076","article-title":"Commitment to the B-lymphoid lineage depends on the transcription factor Pax5","volume":"401","author":"Nutt","year":"1999","journal-title":"Nature"},{"key":"R29-6-20210219","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1182\/blood.V92.4.1308","article-title":"Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas","volume":"92","author":"Krenacs","year":"1998","journal-title":"Blood"},{"key":"R30-6-20210219","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1073\/pnas.92.12.5709","article-title":"Deregulated expression of PAX5 in medulloblastoma","volume":"92","author":"Kozmik","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"R31-6-20210219","doi-asserted-by":"crossref","first-page":"8058","DOI":"10.1158\/0008-5472.CAN-08-0153","article-title":"Development of cellular immune responses against PAX5, a novel target for cancer immunotherapy","volume":"68","author":"Yan","year":"2008","journal-title":"Cancer Res"},{"key":"R32-6-20210219","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1182\/blood.V95.7.2198","article-title":"Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1","volume":"95","author":"Gao","year":"2000","journal-title":"Blood"},{"key":"R33-6-20210219","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/sj.leu.2403186","article-title":"Complete remission in a patient with recurrent acute myeloid leukemia induced by vaccination with WT1 peptide in the absence of hematological or renal toxicity","volume":"18","author":"Mailander","year":"2004","journal-title":"Leukemia"},{"key":"R34-6-20210219","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/blood-2007-08-108241","article-title":"Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies","volume":"111","author":"Rezvani","year":"2008","journal-title":"Blood"},{"key":"R35-6-20210219","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/ijc.21817","article-title":"Generation of tumoricidal PAX3 peptide antigen specific cytotoxic T lymphocytes","volume":"119","author":"Rodeberg","year":"2006","journal-title":"Int J Cancer"},{"key":"R36-6-20210219","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/j.1460-2075.1991.tb08054.x","article-title":"Pax-3, a novel murine DNA binding protein expressed during early neurogenesis","volume":"10","author":"Goulding","year":"1991","journal-title":"Embo J"},{"key":"R37-6-20210219","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/nature03594","article-title":"A Pax3\/Pax7-dependent population of skeletal muscle progenitor cells","volume":"435","author":"Relaix","year":"2005","journal-title":"Nature"},{"key":"R38-6-20210219","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0925-4773(00)00569-4","article-title":"Transcription factors in melanocyte development: distinct roles for Pax-3 and Mitf","volume":"101","author":"Hornyak","year":"2001","journal-title":"Mech Dev"},{"key":"R39-6-20210219","first-page":"5443","article-title":"Predominant expression of alternative PAX3 and PAX7 forms in myogenic and neural tumor cell lines","volume":"59","author":"Barr","year":"1999","journal-title":"Cancer Res"}],"container-title":["Journal of Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CJI.0b013e31819d4e09","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:54:55Z","timestamp":1786038895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002371-200905000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/cji.0b013e31819d4e09","relation":{},"ISSN":["1524-9557"],"issn-type":[{"value":"1524-9557","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}